Diclofenac Sodium
- Product NDC
- 76420-861
- 11-digit product format
- 764200861
- Labeler code
- 76420
- Product ID
- 76420-861_239fc4df-8f2c-e524-e063-6394a90a2bae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diclofenac Sodium
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- Asclemed USA, Inc
- Application
- ANDA213040
- Marketing category
- ANDA
- Marketing start
- 2023-02-03
- Substance
- DICLOFENAC SODIUM
- Active strength
- 20 mg/g
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213040-001 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213040-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213040-001 | DICLOFENAC SODIUM | 2% | SOLUTION / TOPICAL | AB | 2023-02-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213040-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213040-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213040-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213040-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213040-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213040-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213040-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213040-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213040-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A213040-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213040-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213040-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213040-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A213040-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213040-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A213040-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A213040-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213040-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213040-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213040-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213040-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A213040-001 | AB | 1 | 053a50430f4f… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213040-001 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diclofenac Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DICLOFENAC SODIUM | 20 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| QTG126297Q | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1487074 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2e3e6de9-7e07-4df3-9fea-ac50ddcde840 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 111d457e-3138-4512-b0ba-d0cd760c4055 | Product name | 3 | 20250225 |
| 0426261e-1bb9-b78b-abd2-80da765a7e3e | Product name | 2 | 20240513 |
| 7b6158ae-c3f4-3d73-c35f-6f5d18b9efd7 | Product name | 5 | 20240320 |
| 0ac2f11f-f58d-baf2-71a0-680993b48a61 | Product name | 2 | 20231211 |
| 855d63c3-b090-4636-8fc7-6d39ad23c44f | Product name | 1 | 20230829 |
| bb58f410-04be-65dd-9211-e89ead899698 | Product name | 6 | 20230323 |
| 0fcbc38a-8b29-3348-1cef-5222ea53484f | Product name | 4 | 20220516 |
| c4e1eedc-aca2-4551-8382-89144ed9d049 | Product name | 3 | 20220126 |
| 8d368a34-1453-43ea-828d-0dbcd72b8794 | Product name | 8 | 20210622 |
| d6bab9d2-edce-a213-4796-226ab15472c3 | Product name | 6 | 20200616 |
| 2487e6ef-d419-42fc-aaf8-7acc805d2370 | Product name | 2 | 20170718 |
| e071c814-e5e7-e7ed-ec76-428765d9c66b | Product name | 2 | 20151120 |
| 93148e06-b8d7-4e6c-853e-62f807d17fbb | Product name | 1 | 20151014 |
| dbb00be6-fb1c-4b0a-a770-31f7e05e247e | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76420-861-04 | Diclofenac Sodium | 112 g in 1 BOTTLE | SOLUTION | 112 | 1 | |
| 76420-861-04 | Diclofenac Sodium | 1 in 1 CARTON | SOLUTION | 1 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76420-861-04 | GM - Gram | 76420-861 | 44807c34-6a88-4a47-8f6f-0125ae353cc5 | 1 | 2025-01-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC SODIUM | Aurolife Pharma LLC | dfb7afdf-5c05-4487-9044-936e151e5ba6 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 15b280a1-4964-4636-833b-3db44044d289 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | ca0f9295-4933-48d6-9387-90345fd5dcaa | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | NorthStar Rx LLC | fd467c1a-6463-4d92-9960-3e308c733edb | 2025-01-10 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | Proficient Rx LP | ba4677e4-00f8-44f6-a69b-e88ca28f6b2b | 2024-11-01 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | Asclemed USA, Inc | 2e3e6de9-7e07-4df3-9fea-ac50ddcde840 | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 76420-861 |
| Diclofenac Sodium Topical Solution | DICLOFENAC SODIUM TOPICAL SOLUTION | Direct_Rx | 15c2cd6d-b7c2-d927-e063-6394a90aa63e | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
| Diclofenac Sodium | DICLOFENAC SODIUM | Proficient Rx LP | f104f8fb-066f-4bbf-8894-3b3ed1b8266d | 2024-03-01 | Boxed warning, Warnings, Adverse reactions | 213040 ANDA213040 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1487074 | diclofenac sodium 2 % Topical Solution | PSN | 2e3e6de9-7e07-4df3-9fea-ac50ddcde840 | 1 |
| 1487074 | diclofenac sodium 20 MG/ML Topical Solution | SCD | 2e3e6de9-7e07-4df3-9fea-ac50ddcde840 | 1 |
| 1487074 | diclofenac sodium 2 % Topical Solution | SY | 2e3e6de9-7e07-4df3-9fea-ac50ddcde840 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76420-861-04 | 76420086104 | 1 BOTTLE in 1 CARTON (76420-861-04) / 112 g in 1 BOTTLE | 1 bottle | 2024-10-04 | No | No | Current |